Aubagio® delays onset of clinically definite MS, study

Aubagio is an oral treatment approved for MS.

Aubagio® delays onset of clinically definite MS, study

Postby MSUK » Thu Apr 25, 2013 1:58 am

Genzyme, a Sanofi company, announced today positive top-line results from the TOPIC trial for Aubagio (teriflunomide). The trial was designed to assess whether early initiation of Aubagio (teriflunomide) in patients who experienced their first neurological symptoms consistent with Clinically Isolated Syndrome (CIS) can prevent or delay conversion to clinically definite multiple sclerosis (CDMS)..... Read More - http://www.ms-uk.org/index.cfm/aubagio
MS-UK - http://www.ms-uk.org/
User avatar
MSUK
Family Elder
 
Posts: 2120
Joined: Wed Oct 14, 2009 3:00 pm

Return to Aubagio (teriflunomide)

 


  • Related topics
    Replies
    Views
    Last post

Who is online

Users browsing this forum: No registered users


Contact us | Terms of Service